InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (23 ops.)
Insider track record
OtherDisclosed buys
1
Disclosed sells
23
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Formela Jean Francois. Director active across 4 companies, notably Intellia Therapeutics, Inc.. In total, 28 disclosures have been published. Breakdown: 1 buy · 23 sells. Total volume traded: €8.3m. Activity tracked since 11 June 2021. The latest transaction was filed on 26 August 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Formela Jean Francois
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations28 total
249 shares@ US$13.96Common StockSEC:0001030575-26-000012:0
51 shares@ US$13.96Common StockSEC:0001030575-26-000012:1
23,584 shares@ US$14.000.16% mcap10.6% of flowCommon StockSEC:0001030575-26-000010:0
4,884 shares@ US$14.000.034% mcap2.2% of flowCommon StockSEC:0001030575-26-000010:1
1,775 shares@ US$13.960.013% mcap0.9% of flowCommon StockSEC:0001030575-26-000008:0
368 shares@ US$13.960.0026% mcap0.2% of flowCommon StockSEC:0001030575-26-000008:1
85,955 shares@ US$14.030.59% mcap45.4% of flowCommon StockSEC:0001030575-26-000006:0
14,745 shares@ US$14.030.10% mcap7.8% of flowCommon StockSEC:0001030575-26-000006:1
817 shares@ US$13.960.0056% mcap0.4% of flowCommon StockSEC:0001030575-26-000006:2
8,506 shares@ US$13.960.058% mcap4.5% of flowCommon StockSEC:0001030575-26-000006:3
3,382 sharesCommon StockSEC:0001030575-26-000004:0
580 sharesCommon StockSEC:0001030575-26-000004:1
101,579 sharesCommon StockSEC:0001030575-26-000004:2
17,426 sharesCommon StockSEC:0001030575-26-000004:3
40,679 sharesCommon StockSEC:0001030575-26-000004:4
666 sharesCommon StockSEC:0001030575-26-000004:5
6,979 sharesCommon StockSEC:0001030575-26-000004:6
114 sharesCommon StockSEC:0001030575-26-000004:7
2,441 shares@ US$13.953.0% of flowCommon StockSEC:0001030575-26-000002:0
419 shares@ US$13.950.5% of flowCommon StockSEC:0001030575-26-000002:1
17,857 shares@ US$56.0096.5% of flowCommon StockSEC:0001415889-24-011388:0
942,075 sharesCommon StockSEC:0000950170-23-060597:0
5,197 shares0Common StockSEC:0001209191-22-037598:0
125,000 shares@ US$16.00100.0% of flowCommon StockSEC:0001209191-21-069645:0
Canonical exit: 28 Jun 2021 (T+90)
2,055,063 shares@ €32.189850.0% of flowCommon StockSEC:0001209191-21-056045:0
25 of 28 declarations
About Formela Jean Francois
FORMELA JEAN FRANCOIS is a declarant linked to Korro Bio, Inc., Intellia Therapeutics, Inc., Ikena Oncology, Inc. and Translate Bio, Inc. He has 22 filings in total, and across the recent filings available, the buy amount is EUR 1705960 and the sell amount is EUR 6189824, with transactions ranging from 2021-06-15 to 2026-07-07.
